Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1999
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052536A1 Use of at least a plant extract of the compositae family, such as the genus bellis
10/21/1999WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999WO1999046245A3 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
10/21/1999WO1999040061A3 Novel dihydroxyhexanoic acid derivatives
10/21/1999WO1999039712A9 Substituted semicarbazides and the use thereof
10/21/1999WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999DE19818614A1 New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999DE19817461A1 New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999DE19817459A1 New heterocyclic amide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999DE19816882A1 Use of known and new triazolone derivatives as medicaments, especially for treatment of neurodegenerative disorders and cerebral ischemia
10/21/1999DE19816880A1 New diaryl substituted heterocyclic compounds are AMPA receptor antagonists useful in treatment of neurodegenerative disorders and cerebral ischemia
10/21/1999DE19816857A1 Novel adenosine antagonists useful in treatment of e.g. neurodegenerative, pulmonary, renal and cardiovascular disorders
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328211A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999CA2327882A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999CA2327782A1 Azabicyclic 5ht1 receptor ligands
10/21/1999CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999EP0740655B1 Metalloproteinase inhibitors
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999CN1232448A Vitamin D analogues
10/20/1999CN1232394A Solid oral dosage forms of valsartan
10/20/1999CN1232025A Pyrrolidine and piperidine derivatives
10/20/1999CN1045777C Tetracyclic derivs. process of preparation and use
10/20/1999CN1045770C Method for preparation of 1-biphenylmethyl imidazole derivs.
10/20/1999CN1045769C Process for preparing sulfurous derivs. of imidazole
10/20/1999CN1045768C Angiotension II antagonists compounds, preparing method and use thereof
10/19/1999US5969184 Amide compounds
10/19/1999US5969151 Pyrazole compounds
10/19/1999US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999US5969017 Methods of treating or preventing cardiac arrhythmia
10/19/1999US5968985 Benzoylguanidine derivatives as medicaments
10/19/1999US5968983 Administering a mixture of arginine and an inhibitor of a reductase
10/19/1999US5968971 Endothelin receptor antagonists
10/19/1999US5968967 Pyrazolones derivatives
10/19/1999US5968963 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
10/19/1999US5968959 Administering phospholamban inhibitor
10/19/1999US5968950 Treatment of hypertriglyceridemia with decreasing apo b secretion for treatment of atheriosclerosis, pancreatitis, obesity or diabetes
10/19/1999US5968948 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/19/1999US5968927 Azepino-indole compounds; treatment of inflammatory, autoimmune and neurodegenerative diseases, prevention of ischemic injury
10/19/1999US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968818 Nucleic acid coding an enzyme whose presence can be used to acess sensitivity to atherosclerosis
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968770 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
10/19/1999US5968516 Soybean drug and new method of extracting soybean saponins
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051598A1 SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES: SELECTIVE NEUROPEPTIDE y RECEPTOR LIGANDS
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051571A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999WO1999051260A2 Treatment of cardiac hypertrophy
10/14/1999WO1999051252A1 Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
10/14/1999WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999WO1999051203A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999WO1999051097A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999WO1999045011A8 Glycine transport inhibitors
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999042089A3 Use of thiadiazolo[4,3-a]pyridine derivatives
10/14/1999WO1999039702A3 Method for regulating size and growth of vascularized normal tissue
10/14/1999WO1999033840B1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action
10/14/1999CA2327095A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999CA2327068A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326759A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/14/1999CA2324381A1 An integrin heterodimer and a subunit thereof
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0949242A1 Aromatic amine derivatives having nos inhibitory effect
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948611A1 Ve-cadherin promoter and its uses
10/13/1999EP0948524A1 Peptides agonists of bradykinine b 2? receptor
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/13/1999EP0948499A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
1 ... 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 ... 1595